Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Corporate Executive VP & CCO | November 07, 2024 | November 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date November 07, 2024 · Filed November 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 23,337 |
Reported balance
After 2024-11-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-11-07 · Gift · Disposed 470 · Balance 23,337 F1: Reflects the exempt transfer pursuant to Rule 16a-13 of 965 shares held by the reporting person to William D. Barbo Revocable Trust. |
| Common StockSEC Table I · non-derivative | Direct | 2,468 |
Reported balance
Holding disclosure · report date 2024-11-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,468 |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the exempt transfer pursuant to Rule 16a-13 of 965 shares held by the reporting person to William D. Barbo Revocable Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 07, 2020 Filed Feb 10, 2020 20:23 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 3,844 | $159.07 | $611,465.08 |
DisclosureSEC source: 0001127602-20-004554 · form4.xml · nonDerivative · entry 2 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,832 Read SEC document |
| February 07, 2020 Filed Feb 10, 2020 20:23 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 10,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004554 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,676 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 24, 2017. Read SEC document |
| June 25, 2019 Filed Feb 7, 2020 16:50 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 770 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-004202 · form5.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,931 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 96 | $126.19 | $12,114.24 |
DisclosureSEC source: 0001127602-19-020218 · form4.xml · nonDerivative · entry 13 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,701 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 13 | $126.15 | $1,639.95 |
DisclosureSEC source: 0001127602-19-020218 · form4.xml · nonDerivative · entry 12 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,797 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 21 | $126.10 | $2,648.00 |
DisclosureSEC source: 0001127602-19-020218 · form4.xml · nonDerivative · entry 11 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,810 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 4 | $126.09 | $504.36 |
DisclosureSEC source: 0001127602-19-020218 · form4.xml · nonDerivative · entry 10 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,831 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $126.08 | $12,608.00 |
DisclosureSEC source: 0001127602-19-020218 · form4.xml · nonDerivative · entry 9 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,835 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $126.03 | $12,603.00 |
DisclosureSEC source: 0001127602-19-020218 · form4.xml · nonDerivative · entry 8 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,935 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 21 | $126.00 | $2,645.90 |
DisclosureSEC source: 0001127602-19-020218 · form4.xml · nonDerivative · entry 7 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,035 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $125.98 | $12,598.00 |
DisclosureSEC source: 0001127602-19-020218 · form4.xml · nonDerivative · entry 6 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,056 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 398 | $125.93 | $50,120.14 |
DisclosureSEC source: 0001127602-19-020218 · form4.xml · nonDerivative · entry 5 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,156 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 50 | $125.89 | $6,294.25 |
DisclosureSEC source: 0001127602-19-020218 · form4.xml · nonDerivative · entry 4 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,554 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 20 | $125.88 | $2,517.60 |
DisclosureSEC source: 0001127602-19-020218 · form4.xml · nonDerivative · entry 3 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,604 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $125.87 | $37,761.00 |
DisclosureSEC source: 0001127602-19-020218 · form4.xml · nonDerivative · entry 2 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,624 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 30 | $125.84 | $3,775.20 |
DisclosureSEC source: 0001127602-19-020218 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,924 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,158 | $0.00 Strike: $76.67 | $0.00 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · derivative · entry 31 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,158 shares Expires 2020-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 120 | $125.76 | $15,091.20 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 30 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,954 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $125.75 | $25,150.00 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 29 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,074 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $125.74 | $12,573.50 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 28 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,274 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $125.73 | $12,573.00 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 27 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,374 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $125.72 | $12,572.00 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 26 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,474 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $125.70 | $12,569.50 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 25 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,574 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $125.53 | $37,659.00 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 24 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,674 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 39 | $125.52 | $4,895.28 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 23 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,974 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $125.29 | $12,529.00 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 22 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,013 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 50 | $125.26 | $6,263.00 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 21 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,113 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $125.23 | $50,092.00 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 20 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,163 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $125.18 | $12,518.00 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 19 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,563 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $125.13 | $25,026.00 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 18 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,663 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $125.12 | $12,512.00 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 17 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,863 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $125.04 | $12,504.00 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 16 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,963 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $125.03 | $25,006.00 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 15 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,063 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 407 | $125.02 | $50,883.14 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 14 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,263 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 193 | $125.01 | $24,126.93 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 13 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,670 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $125.00 | $37,500.00 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 12 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,863 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 69 | $125.00 | $8,624.66 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 11 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,163 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 51 | $124.98 | $6,373.98 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 10 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,232 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $124.97 | $12,496.50 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 9 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,283 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 2 | $124.95 | $249.90 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 8 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,487 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 104 | $124.96 | $12,995.84 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 7 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,383 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 498 | $124.94 | $62,220.12 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 6 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,489 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 331 | $124.92 | $41,348.52 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 5 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,987 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $124.90 | $12,490.00 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 4 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,318 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 397 | $124.89 | $49,581.33 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 3 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,418 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 44 | $124.88 | $5,494.72 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 2 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,815 Read SEC document |
| May 29, 2019 Filed May 30, 2019 12:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 2,158 | $76.67 | $165,453.86 |
DisclosureSEC source: 0001127602-19-020216 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2019 Filed Feb 28, 2019 14:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 218 | $140.71 | $30,674.78 |
DisclosureSEC source: 0001127602-19-008792 · form4.xml · nonDerivative · entry 2 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,201 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 22 | $141.38 | $3,110.25 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 28 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,701 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 700 | $141.36 | $98,952.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 27 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,723 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.